NCT06184750 2026-03-19
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
9 trialsNCT05941520 2026-03-18
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06075953 2026-03-16
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT01266642 2026-03-11
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06617455 2026-03-02
VEnT
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT06868238 2026-02-18
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
University of Florida
Phase 2 Withdrawn
NCT05023967 2026-01-05
Metformin and Nightly Fasting in Women With Early Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03345420 2025-12-30
NOVEMBER
University of Utah
Phase 2 Completed
NCT00165256 2025-12-29
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Dana-Farber Cancer Institute
Phase 2 Active not recruiting